<?xml version="1.0" encoding="UTF-8"?>
<ref id="B19-pharmaceutics-13-00387">
 <label>19.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Salunke</surname>
    <given-names>S.</given-names>
   </name>
   <name>
    <surname>Liu</surname>
    <given-names>F.</given-names>
   </name>
   <name>
    <surname>Batchelor</surname>
    <given-names>H.</given-names>
   </name>
   <name>
    <surname>Walsh</surname>
    <given-names>J.</given-names>
   </name>
   <name>
    <surname>Turner</surname>
    <given-names>R.</given-names>
   </name>
   <name>
    <surname>Ju</surname>
    <given-names>T.R.</given-names>
   </name>
   <name>
    <surname>Tuleu</surname>
    <given-names>C.</given-names>
   </name>
   <collab>on behalf of European Paediatric Formulation Initiative (EuPFI)</collab>
  </person-group>
  <article-title>European Paediatric Formulation Initiative (EuPFI)â€”Formulating Ideas for Better Medicines for Children</article-title>
  <source>AAPS PharmSciTech</source>
  <year>2016</year>
  <volume>18</volume>
  <fpage>257</fpage>
  <lpage>262</lpage>
  <pub-id pub-id-type="doi">10.1208/s12249-016-0584-1</pub-id>
  <pub-id pub-id-type="pmid">27422653</pub-id>
 </element-citation>
</ref>
